Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1500364rdf:typepubmed:Citationlld:pubmed
pubmed-article:1500364lifeskim:mentionsumls-concept:C0441833lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C0031959lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C0163056lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C0077116lld:lifeskim
pubmed-article:1500364lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:1500364pubmed:issue6lld:pubmed
pubmed-article:1500364pubmed:dateCreated1992-9-14lld:pubmed
pubmed-article:1500364pubmed:abstractTextSiastatin B analogues, optically active 2-(trifluoroacetamide)- 3,4,5-trihydroxypiperidines having nitromethyl, aminomethyl and carboxyl branched groups at C-5, and (+)-(2R,3R,4R,5R)-5-(aminomethyl)-3,4,5-trihydroxy-2- (hydroxyacetamido)piperidine have been obtained total synthetically from D-ribono-1,4-lactone. Some analogues have inhibitory activity against some glycosidases, and (+)-(2R,3R,4R,5R)-2-(trifluoroacetamido)-3,4,5-trihydroxypiperi dine-5-carboxylic acid showed a marked inhibitory activity against beta-glucuronidase.lld:pubmed
pubmed-article:1500364pubmed:languageenglld:pubmed
pubmed-article:1500364pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1500364pubmed:citationSubsetIMlld:pubmed
pubmed-article:1500364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1500364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1500364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1500364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1500364pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1500364pubmed:statusMEDLINElld:pubmed
pubmed-article:1500364pubmed:monthJunlld:pubmed
pubmed-article:1500364pubmed:issn0021-8820lld:pubmed
pubmed-article:1500364pubmed:authorpubmed-author:TakeuchiTTlld:pubmed
pubmed-article:1500364pubmed:authorpubmed-author:KudoTTlld:pubmed
pubmed-article:1500364pubmed:authorpubmed-author:KondoSSlld:pubmed
pubmed-article:1500364pubmed:authorpubmed-author:NishimuraYYlld:pubmed
pubmed-article:1500364pubmed:issnTypePrintlld:pubmed
pubmed-article:1500364pubmed:volume45lld:pubmed
pubmed-article:1500364pubmed:ownerNLMlld:pubmed
pubmed-article:1500364pubmed:authorsCompleteYlld:pubmed
pubmed-article:1500364pubmed:pagination963-70lld:pubmed
pubmed-article:1500364pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1500364pubmed:meshHeadingpubmed-meshheading:1500364-...lld:pubmed
pubmed-article:1500364pubmed:meshHeadingpubmed-meshheading:1500364-...lld:pubmed
pubmed-article:1500364pubmed:meshHeadingpubmed-meshheading:1500364-...lld:pubmed
pubmed-article:1500364pubmed:meshHeadingpubmed-meshheading:1500364-...lld:pubmed
pubmed-article:1500364pubmed:year1992lld:pubmed
pubmed-article:1500364pubmed:articleTitleTotally synthetic analogues of siastatin B. II. Optically active piperidine derivatives having trifluoroacetamide and hydroxyacetamide groups at C-2.lld:pubmed
pubmed-article:1500364pubmed:affiliationInstitute of Microbial Chemistry, Tokyo, Japan.lld:pubmed
pubmed-article:1500364pubmed:publicationTypeJournal Articlelld:pubmed